Labeling of Hinokitiol with Y-90 for Potential Radionuclide Therapy of Hepatocellular Carcinoma - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Processes Année : 2021

Labeling of Hinokitiol with Y-90 for Potential Radionuclide Therapy of Hepatocellular Carcinoma

Résumé

Hepatocellular carcinoma (HCC), the most common form of primary liver tumors, is the fifth cancer in the world in terms of incidence, and third in terms of mortality. Despite significant advances in the treatment of HCC, its prognosis remains bleak. Transarterial radioembolization with radiolabeled microspheres and Lipiodol has demonstrated significant effectiveness. Here we present a new, simple radiolabeling of Lipiodol with Yttrium-90, for the potential treatment of HCC.

Domaines

Chimie
Fichier principal
Vignette du fichier
processes-09-00940-v2.pdf (2.71 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03281480 , version 1 (08-07-2021)

Licence

Paternité

Identifiants

Citer

Christelle Bouvry, Valerie Ardisson, Nicolas Noiret, Etienne Garin, Nicolas Lepareur. Labeling of Hinokitiol with Y-90 for Potential Radionuclide Therapy of Hepatocellular Carcinoma. Processes, 2021, 9 (6), ⟨10.3390/pr9060940⟩. ⟨hal-03281480⟩
57 Consultations
32 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More